Unique access to optimized global development
We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies:
• Integrated development planning through a senior development team
• Patient recruitment in key global geographies through validated partners
• Flexibility and agility of an SME
• Global regulatory track record
• Single point of contact
We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network.
We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration.
Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions
Optimizing global medical product development
Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners.
For European biotech companies this approach maximize the value creation through
• Easy access to a seasoned VP team of developers
• Track record from CMC through to commercialization
• Insight and experience to obtain key regulatory buy in from FDA and EMA
• Patient recruitment in key global geographies
For European pharmaceutical companies we add value through
• Combining European, US and Indian core competences when executing your studies
• Guiding and managing functional outsourcing of clinical development services
• Obtaining and maintaining global registrations through our network
This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place.
Identifying the most optimal plan to achieve your specific development goals
Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals.
Jeppe Skytte Sales and Business Development Manager MSc, PhD
Our VP team
Claes Christian Strom Vice President, Medical Affairs MD, PhD, BBA
Lars Lykke Thomsen Vice President, Chief Medical Officer MD, PhD, DMSc
Kim Nordfjeld Vice President, Quality and Registration PhD Pharmacy
Jens Fabricius Vice President, Marketing and Business Operations BCommerce, EMBA
Executive Vice President, Chief Financial Officer
To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte:
Jeppe Skytte Sales and Business Development Manager MSc, PhD T: +45 59 48 59 85 (direct) T: +45 22 84 26 56 (mobile) E: firstname.lastname@example.org
Pharmacosmos CRO offices
Pharmacosmos CRO A/S Roervangsvej 30 DK-4300 Holbaek Denmark
Learn more about Pharmacosmos
Visit our corporate website: www.pharmacosmos.com
Novo Seeds is a life science supporting program launched by the Novo Nordisk...
HÅRklinikken UK 2013_0515
HÅRklinikken DK 2013_0515
Peter Rasborg fortæller om sin passion for revision og om at få tingene til...
BGI, the world’s largest genomics organization, opened on February 10th its...